One of the major problems faced by clinicians in treating patients with a rare disease is that without the weight of clinical data supporting therapeutic options, clinical management is often based on opinion or anecdotal evidence. Ebner et al. (2015) describe how European clinicians are trying to overcome this critical data shortage for pediatric autosomal Read the rest of this article
The post Biobanking for Studying Rare Disease: ARegPKD and Pediatric Kidney Disease appeared first on Accelerating Science.
from Accelerating Science » Amanda Maxwell http://ift.tt/1poRb3H